section name header

Y-Site Injection Compatibility (1:1 Mixture)

Milrinone lactate

(Mfr: APO)(Conc: 0.2 mg/mLq)

I

Ceftobiprole medocaril sodium

(Mfr: JJ)(Conc: 2.67 mg/mLa,b)

Remarks:

Increase in measured haze with or without subvisible microparticles

Ref:

4128,4129